2020
DOI: 10.21203/rs.3.rs-58756/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Identification of Novel Hub Genes Associated With Gastric Cancer Using Integrated Bioinformatics Analysis

Abstract: Background: Gastric cancer (GC) is one of the most common solid malignant tumors worldwide with a high-recurrence-rate. Identifying the molecular signatures and specific biomarkers of GC might provide novel clues for GC prognosis and targeted therapy.Methods: Gene expression profiles were obtained from the ArrayExpress and Gene Expression Omnibus database. Differentially expressed genes (DEGs) were picked out by R software. The hub genes were screened by cytoHubba plugin. Their prognostic values were assessed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…It stimulates the formation of tubulin polymers and results in tubulin fragments being formed at microtubule ends [29]. CEP55, HMMR, CDKN3, and CDC25C are essential for cell cycle progression [30][31][32][33]. PRTN3 is a serine protease found on 9 Oxidative Medicine and Cellular Longevity neutrophils and monocytes and binds to the surface of the endothelium but can also be internalized which induces apoptosis [34].…”
Section: Discussionmentioning
confidence: 99%
“…It stimulates the formation of tubulin polymers and results in tubulin fragments being formed at microtubule ends [29]. CEP55, HMMR, CDKN3, and CDC25C are essential for cell cycle progression [30][31][32][33]. PRTN3 is a serine protease found on 9 Oxidative Medicine and Cellular Longevity neutrophils and monocytes and binds to the surface of the endothelium but can also be internalized which induces apoptosis [34].…”
Section: Discussionmentioning
confidence: 99%
“…These show that elevated RHAMM expression is characteristic of most cancers and prognostic of a poor outcome in many. For example, elevated RHAMM expression is an indicator of poor prognosis in breast cancer [ 119 , 120 , 121 ], multiple myeloma [ 122 ], oral squamous cell carcinoma [ 123 ], ovarian cancer [ 124 ], lung cancer [ 125 ], prostate cancer [ 126 ], colon cancer [ 127 ], and gastric cancer [ 128 ]. However, histology analyses of these human tumors reveal that RHAMM expression is heterogeneous, and high RHAMM expression is often limited to a small subset of cancer cells [ 119 ].…”
Section: Rhamm Multi-functions In Cancermentioning
confidence: 99%